Net Income - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Net Income Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Net Income
-€26.2m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Net Income
-€32.4m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Nanobiotix SA
PAR:NANO
Net Income
-€39.7m
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
Innate Pharma SA
PAR:IPH
Net Income
-€34.1m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Genfit SA
NASDAQ:GNFT
Net Income
-€28.9m
CAGR 3-Years
34%
CAGR 5-Years
18%
CAGR 10-Years
-9%
Eurobio Scientific SA
PAR:ALERS
Net Income
€4.8m
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Net Income?
Net Income
-26.2m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Net Income amounts to -26.2m EUR.

What is Gensight Biologics SA's Net Income growth rate?
Net Income CAGR 5Y
5%

Over the last year, the Net Income growth was 5%. The average annual Net Income growth rates for Gensight Biologics SA have been 8% over the past three years , 5% over the past five years .

Back to Top